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ABSTRACT
The Arabidopsis protein AINTEGUMENTA (ANT) is
an important regulator of organ growth during
¯ower development. ANT is a member of the AP2
subclass of the AP2/ERF family of plant-speci®c
transcription factors. These proteins contain either
one or two copies of a DNA-binding domain called
the AP2 domain. Here, it is shown that ANT can act
as a transcriptional activator in yeast through
binding to a consensus ANT-binding site. This activ-
ity was used as the basis for a genetic screen to
identify amino acids that are critical for the DNA
binding ability of ANT. Mutants that showed
reduced or no activation of a reporter gene under
the control of ANT-binding sites were identi®ed. The
mutations identi®ed in the screen as well as
additional site-directed mutations suggest that the
mode of DNA recognition by members of the AP2
subfamily is distinct from that of ERF proteins.
Surprisingly, it appears that each AP2 domain of
ANT uses different amino acids to contact DNA.
Identi®cation of several linker mutations argues that
this sequence acts in the positioning of each AP2
domain on the DNA or makes direct DNA contacts.
INTRODUCTION
The Arabidopsis protein AINTEGUMENTA (ANT) functions
in several aspects of reproductive development. ANT
promotes growth within ¯oral meristems and developing
organ primordia (1±4). It is required for integument initiation
in ovules (1,2,5,6) and plays roles in gynoecium (7) and petal
development (8). ANT is a member of a large family of plant
transcriptional regulators called the AP2/ERF family (1,2). All
members of this family contain at least one copy of a DNA-
binding domain called the AP2 domain (9). The 144 AP2/ERF
proteins in the Arabidopsis genome (10) can be subdivided
into ®ve groups: the AP2 subfamily, RAV subfamily, DREB
subfamily, ERF subfamily, and others (11). Members of the
AP2 subfamily contain two AP2 domains connected by a
25 amino acid conserved linker. Members of the other
subgroups contain a single AP2 domain, which has been
referred to as the ERF domain (12) and GCC box-binding
domain (13).
Structural information is available for one member of the
ERF subfamily, AtERF1. The solution structure of the ERF
domain of AtERF1 bound to the GCC box (5¢-AGCCGCC-3¢)
reveals that the protein uses an antiparallel three-stranded
b-sheet to make major groove contacts (13). The b-sheet packs
against an a-helix that runs approximately parallel to the sheet
(13). This structure is stabilized by an extensive number of
hydrophobic contacts. The majority of DNA contacts are
made by arginine and tryptophan residues located in the
b-sheet (13).
Little is known about the interactions between members of
the AP2 subfamily of proteins and DNA. Previously, we
showed that ANT can bind DNA and that its in vitro consensus
binding site is 5¢-gCAC(A/G)N(A/T)TcCC(a/g)ANG(c/t)-3¢
(14). This sequence is quite distinct from the GCC motif bound
by ERF proteins or the DRE/CRT motif (5¢-A/GCCGAC-3¢)
bound by the DREB subfamily (reviewed in 15). Because of
these differences in DNA binding speci®cities and the fact that
there is little conservation of amino acid identity between AP2
and ERF proteins at ERF DNA-contacting positions, it appears
that these two subfamilies may use distinct DNA binding
mechanisms. That the AP2 domain may exhibit ¯exibility in
its mode of DNA recognition is also suggested by the RAV
subfamily, in which a single AP2 domain is found in
combination with an additional plant-speci®c DNA-binding
domain (the B3 domain).
To test this idea, I have utilized a genetic screen in yeast to
identify amino acids that are critical for the DNA binding
ability of ANT. This screen combined the inherent in®delity of
Taq polymerase and in vivo recombination (16) to generate a
large number of mutants containing alterations within the
DNA-binding region of ANT. Mutants that were no longer
able to activate the expression of a reporter gene under the
control of ANT-binding sites were identi®ed. A secondary
western blot screen eliminated those mutations resulting in
premature termination, frameshifts or grossly altered levels of
expression. This screening procedure identi®ed residues in the
AP2 repeats and linker region of ANT that appear to play
critical roles in DNA binding in vivo. The positions of these
mutations provide strong evidence that each AP2 domain of
ANT makes unique contacts with DNA and that neither
domain utilizes the same mode of DNA recognition as that of
the single AP2 domain of ERF proteins.
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MATERIALS AND METHODS
Plasmid construction
ANT1±555 was PCR ampli®ed using Pfu polymerase (Strata-
gene) and primers ANT-13 (5¢-TTGCGGATCCAT-
GAAGTCTTTTTGTGATAAT-3¢; BamHI site underlined)
and ANT-4 (5¢-TGAATCTAGATTAAGAATCAGCCCAA-
GCAGCGAA-3¢; XbaI site underlined) using ANT cDNA as
template. The PCR product was cloned into the BamHI and
XbaI sites of plitmus28 (New England Biolabs) and pGEM3Z
(Promega). ANTD281±357 was made by replacing the ClaI±
HindIII fragment of ANT1±555/plitmus28 with a PCR product
generated with ANT-24 (5¢-TCAACCCGGGGTTACTAGA-
CATGATACGATC-3¢) and ANT-35 (5¢-CTATCATCGA-
TACTTTTGGACAACGAGAAGACATGAAGAACATGA-
CTAGACAAGAA-3¢) primers and digested with ClaI and
HindIII. ANTD383±451 was made by replacing the NdeI±XbaI
fragment of ANT1±555/plitmus28 with a PCR product gener-
ated by overlap extension PCR with the primers ANT-12
(5¢-GCTGCTCGAGCATATGATCT-3¢), ANT-36 (5¢-ACTA-
GACATGATACCCCTAGAGAAACCACTGCT-3¢), ANT-
37 (5¢-TTCTCTAGGGGTATCATGTCTAGTAACACAC-
TC-3¢) and ANT-4. ANT1±451 was made by replacing the
HindIII±XbaI fragment of ANT1±555/plitmus28 with a PCR
product generated with the primers ANT-10 (5¢-TAGGTC-
TAGATTAACGATCAACATCGTACCTCGT-3¢) and ANT-
3 (5¢-CCAAGAAGAAGCTGCAGAAG-3¢). ANTA423T was
made by replacing the NdeI±HindIII fragment of ANT1±555/
plitmus with a PCR product generated by overlap extension
PCR with the primers ANT-6 (5¢-TCAAGGATCCACTTT-
TGGACAACGAACTTCT-3¢), ANT-7 (5¢-GACAGGATCC-
GTTACTAGACATGATACGATC-3¢), ANT-43 (5¢-GTAA-
GCTTCTGTAGCTTCTTCTTG-3¢) and ANT-44 (5¢-CAA-
GAAGAAGCTACAGAAGCTTAC-3¢). To create an epitope
tagged ANT, an ANT clone that lacked a stop codon was
generated in the BamHI site of pGEM3Z. A double
hemagglutinin (DHA) tag was added by ligating two annealed
oligos DHA-1 (5¢-CTAGATACCCATACGACGTTCCAGA-
CTACGCTGGTTACCCATACGACGTTCCAGACTACGC-
TTAAT-3¢) and DHA-2 (5¢-CTAGATTAAGCGTAGTCTG-
GAACGTCGTATGGGTAACCAGCGTAGTCTGGAACG-
TCGTATGGGTAT-3¢) into the XbaI site of this clone.
ANT(sites)DHA was made by replacing the ClaI±BpmI
fragment of ANT-DHA/pGEM3Z with a PCR product gen-
erated with ANT-50 (5¢-AAATCTATCGATACTTTTGGA-
CAACGTACGTCT-3¢; introduced BsiWI site underlined) and
ANT-51 (5¢-GTTGTTGTTCCTTCGCGCGAGCTCTCC-3¢;
introduced SacI site underlined). Addition of these restriction
sites did not alter the amino acid sequence of the protein.
Those constructs not made in pGEM3Z were subcloned into
pGEM3Z as BamHI±XbaI fragments. The ANT constructs
were subsequently subcloned as KpnI±HincII fragments into
pGAD424 (Clontech) that had been digested with KpnI and
SmaI to remove the GAL4 activation domain. All of these
constructs retain the SV40 T-antigen nuclear localization
signal. The reporter plasmid was made by cloning three copies
of a 29 bp sequence (5¢-CTGTAAGCATCGGGATATGTG-
CACCAAGT-3¢) containing the 16 bp ANT consensus
binding site (indicated in bold) (14) upstream of the lacZ
gene in the vector pLacZi (Clontech). The sequence of each
plasmid was con®rmed using an ABI 377.
PCR
The PCR product for the yeast transformation was generated
by either error-prone PCR (E1±E3) or standard PCR (E4±E8)
using Taq polymerase. Standard PCR provided an error rate of
1±2 nt changes per clone. Primers ANT-15 (5¢-GAGAC-
GACGACAATGGCGGCT-3¢) and ANT-53 (5¢-ACTGACT-
TCTTTGTTGGAACC-3¢) were added to a ®nal concentration
of 1.4 mM and the ANT(sites)DHA plasmid (10±20 ng) was
used as template for both error-prone and standard PCR.
Error-prone PCRs were carried out in 10 mM Tris pH 8.3,
50 mM KCl, 7 mM MgCl2, 0.5 mM MnCl2, 1 mM dCTP,
1 mM dTTP, 0.2 mM dATP and 0.2 mM dGTP. Standard
PCRs were carried out in 10 mM Tris pH 9, 50 mM KCl,
1.5 mM MgCl2, 0.1% Triton X-100, 0.2 mM dCTP, 0.2 mM
dTTP, 0.2 mM dATP and 0.2 mM dGTP. The reactions were
cycled for 12 (E1 and E2), 5 (E3) or 30 rounds (E4±E8) with
denaturation at 94°C for 1 min, annealing at 55°C for 1 min,
extension at 72°C for 3 min and a ®nal cycle of 72°C for 5 min.
For E3, an additional ®ve rounds of standard PCR were
performed on the error-prone PCR product. The products were
puri®ed using a StrataPrep PCR puri®cation column
(Stratagene) and quantitated on a gel. These PCR products
contained 109 and 97 bp of homology with either end of the
gapped plasmid.
Yeast strains and transformation
The yeast reporter strain was made by integration of the
linearized ANT target reporter plasmid into the yeast strain
YM4271 (MATa ura3-52, his3-200, lys2-801, ade2-101,
trp1-901, leu2-3, 112, tyr1-501, gal4-D512, gal80-D538,
ade5::hisG). This new reporter strain (called BK1) was then
transformed with the different ANT constructs or the PCR
product (~200 ng)/gapped plasmid (~200 ng) combination
using a lithium acetate procedure (17). Transformants were
selected on plates containing synthetic medium lacking
leucine and screened for b-galactosidase activity using a
colony-lift ®lter assay. Plasmid DNA was isolated (18) and
sequenced from those mutants showing no (white) or reduced
(light blue) b-galactosidase activity but normal levels of
protein expression.
b-Galactosidase assays
A colony-lift ®lter assay was used to screen the yeast
transformants. Colonies were lifted onto nitrocellulose
membranes (BA85; Schleicher & Schuell) and cells were
lysed by freezing in liquid nitrogen. The thawed membranes
were laid on ®lter paper soaked with 100 mM sodium
phosphate pH 7, 10 mM KCl, 1 mM MgSO4, 38 mM
b-mercaptoethanol and 0.33 mg/ml X-gal and incubated at
30°C overnight. White and light blue colonies were identi®ed
by aligning the membranes to the original plates. Quantitative
b-galactosidase assays were performed on 1.5 ml liquid
cultures grown in synthetic medium lacking leucine. The yeast
cells were harvested by centrifugation, resuspended in
lysis buffer (100 mM potassium phosphate pH 7.8, 0.2%
Triton X-100) and vortexed in the presence of glass beads
(425±600 mm diameter; Sigma). An aliquot of 5 ml of the crude
yeast extract was added to 100 ml of a 1:100 dilution of the
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chemiluminescent substrate Galacton (Applied Biosystems).
After incubation for 1 h at room temperature, the enzyme
activity was terminated and light emission was initiated by the
addition of 150 ml of the accelerator. Luminescence was
measured in a luminometer. The assays were performed in
triplicate. The amount of protein present in each sample was
determined by a Bradford assay. The ratio of b-galactosidase
levels for each truncated construct compared to full-length
ANT was determined.
Western blots
Yeast cultures (5 ml) grown in synthetic medium lacking
leucine were harvested after growth for 2 days at 30°C. The
cells were washed once in 1 ml of cold sterile water and then
lysed in 100 ml lysis buffer (100 mM sodium phosphate pH 7.8,
5 mM EDTA, 0.2% Triton X-100, 2 mM DTT, 80 mg/ml
PMSF and 2 mg/ml each of leupeptin, pepstatin A, antipain and
aprotinin) by vortexing with glass beads for 8 min at 4°C. The
supernatant was collected after centrifugation for 10 min.
Total protein concentration was determined by a Bradford
assay. An aliquot of 10 mg of protein was separated on a 10%
SDS±PAGE gel in Laemmli buffer. The proteins were
transferred onto PVDF nylon membranes (Hybond-P;
Amersham Pharmacia). The blot was air dried, blocked with
5% non-fat dry milk in PBS containing Tween for 1 h,
incubated in a 1:1000 dilution of anti-HA antibody (clone
HA-7; Sigma) for 4 h at room temperature, and incubated in a
1:1000 dilution of a secondary antibody coupled to horse-
radish peroxidase (Bio-Rad) for 2 h at room temperature.
The blots were developed with ECL-Plus (Amersham
Pharmacia) and scanned on a Molecular Dynamics Storm
860 phosphorimager.
Protein expression
The DNA-binding domain (amino acids 276±456) of each
mutant was cloned into the BamHI site of pQE12 (Qiagen)
using PCR and the ANT-6 and ANT-7 primers. Plasmid
sequences were con®rmed by sequencing on an ABI 377.
Proteins were expressed in XL1-Blue MRF¢ Tet Escherichia
coli cells (Stratagene) by induction with 1 mM IPTG. The
cells were grown at 30°C and harvested 8 h post-induction.
The 6-His tagged proteins were puri®ed under denaturing
conditions on Ni-NTA-agarose resin (Qiagen) as described by
the manufacturer.
Gel mobility shift assays
Gel mobility shift assays were performed as described
previously (14) except the binding reactions were left at 4°C
overnight. DNA-binding site probes were prepared as
described previously (14). Quantitation of bound and free
DNA was performed using a Molecular Dynamics Storm 860
phosphorimager.
RESULTS
ANT activates transcription in yeast through binding to
its consensus site
Recently, we isolated DNA sequences to which ANT binds
in vitro (14). I utilized a yeast system to determine whether
ANT can activate transcription when bound to these sites
in vivo. A yeast reporter strain (BK1) containing the lacZ
reporter gene under the control of a multimerized ANT
consensus binding site and the TATA portion of the CYC1
gene (Fig. 1) was utilized for these studies. Full-length ANT
(ANT1±555) expressed in BK1 under the control of the ADH1
promoter produced high b-galactosidase activity, indicating
that the ANT-binding site determined in vitro does function to
control gene expression in vivo. DNA binding experiments
previously indicated that both AP2 repeats are required for
high af®nity in vitro binding to this site (14). To determine
whether both AP2 repeats were required for DNA binding
in vivo, b-galactosidase activity was measured in yeast
expressing ANT proteins lacking either the ®rst
(ANTD281±357) or second (ANTD383±451) AP2 repeat (Fig. 1).
Neither ANTD383±451 nor ANTD281±357 was able to activate
expression of the reporter gene (Fig. 1) while a construct
lacking the C-terminal 104 amino acids (ANT1±451) conferred
high levels of b-galactosidase activity. Since the transcrip-
tional activation domain of ANT maps to the N-terminal half
of the protein (C.Sulli and B.A.Krizek, unpublished observa-
tions), the loss of transcriptional activation when either AP2
repeat is missing suggests that binding to this site in vivo
requires both AP2 repeats.
Genetic screen to isolate mutations in ANT that disrupt
DNA binding
From these preliminary data, it appeared that the BK1 yeast
strain might be a useful tool to further probe ANT±DNA
interactions. I developed a genetic screen utilizing this yeast
strain to rapidly identify amino acids that are critical to the
DNA binding ability of ANT. To determine whether the
screen would work (i.e. whether decreased b-galactosidase
activity in BK1 is observed with single amino acid mutants
that show decreased DNA binding ability in vitro), I tested
ANTA423T. This mutation, which corresponds to that present
in the weak ant-8 allele (3), results in a dramatically reduced
DNA binding ability in vitro (data not shown). BK1 cells
expressing ANTA423T showed no b-galactosidase activity
(Fig. 1 and Table 1). Thus, it appeared that the BK1 strain
would be an appropriate system for identifying mutants with
reduced or no DNA binding ability.
To generate mutations in just the DNA-binding domain of
ANT, I utilized a method (16) involving recombination
between Taq-derived PCR products corresponding to the
AP2 repeat region of ANT and a gapped ANT plasmid lacking
the AP2 repeat region (Fig. 2). Homology between the ends of
the PCR product and the gapped plasmid allowed in vivo
recombination between these DNA pieces. Yeast transform-
ants were initially screened for b-galactosidase activity. To
eliminate mutations resulting in premature truncations or
grossly altered stability of the protein, a secondary western
blot screen was performed on all mutants showing reduced
or no b-galactosidase activity (Fig. 3A). Each of the b-
galactosidase phenotypes was con®rmed by re-transformation
of the BK1 yeast strain with DNA from the individual clone
(Fig. 3B).
Characterization of mutants identi®ed by the screen
Using this two-step screening procedure, 28 individual
colonies were identi®ed that expressed a full-length
ANT protein but showed either reduced (four colonies) or
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no (24 colonies) b-galactosidase activity. Each clone had
either one (19 clones) or two (nine clones) amino acid changes
within the DNA-binding region of ANT (Table 1). Mutations
in seven positions (V287, Y318, L319, D333, L337, F379 and
S384) were represented multiple times within the collection.
Quantitative b-galactosidase assays were performed for 10 of
the mutants. There is a good correlation between the results
from the quantitative b-galactosidase assay and those from the
colony-lift assay. White colonies produced b-galactosidase
levels at least 1000-fold lower than ANT while light blue
colonies produced b-galactosidase levels at least 100-fold
lower than ANT (Table 1).
The 37 mutations correspond to 24 different amino acid
positions within ANT. These include 13 positions within the
®rst AP2 repeat (ANT-AP2R1), four positions within the
linker and seven positions within the second AP2 repeat
(ANT-AP2R2). The positions of these mutations are shown in
Figure 4A. For the most part, the mutations mapped to
different positions within the ®rst and second AP2 repeats.
The single ERF domain from AtERF1 folds into a compact
structure consisting of a three-stranded b-sheet that packs
against an a-helix (13). Amino acids from each of the
three b-strands as well as two residues N-terminal to the ®rst
b-strand contribute to DNA binding (13). These DNA-
contacting positions include ®ve arginines (R147, R150,
R152, R162 and R170) and two tryptophans (W154 and
W172). Three of the arginines and the two tryptophan residues
contact both the nucleotide base and the sugar±phosphate
backbone. The secondary structural elements and
DNA-contacting residues of AtERF1 are shown in Figure 4.
A large number of hydrophobic residues (Y146, V149,
F157, A159, I161, V171, L173, F176, A179, A182, A183,
A185, Y186, A189, A190, A198, L200 and F202 in AtERF1)
stabilize the packing of these secondary structural elements
against one another (13). The positions of these hydrophobic
residues are well conserved in the sequences of ANT-R1 and
ANT-R2, suggesting that each AP2 repeat of ANT might fold
into a similar three-dimensional structure as the ERF domain
of AtERF1. Homology modeling using Swiss-Model predicts
an a-helix in each AP2 domain similar in length and location
to the a-helix in AtERF1 (Fig. 5) (19±21). These models
differed from AtERF1 however in the b-sheet region. No
b-sheet was predicted in ANT-AP2R2 while that proposed for
ANT-AP2R1 consisted of two strands at somewhat different
positions than the b-strands in AtERF1 (Fig. 5).
In the absence of any structural information on the AP2
domain, I compared the positions identi®ed in the screen to
positions within AtERF1 as determined by aligning the
sequences using Clustal X. This alignment is shown in
Figure 4. Approximately half of the mutations (13 of 24) map
to regions predicted to fold into secondary structural elements
based on the alignment with AtERF1. Although the a-helix
makes no contacts with DNA in the AtERF1 structure,
mutation of two positions within the putative helix of both
ANT-AP2R1 and ANT-AP2R2 results in loss of function in
the yeast assay. These two positions are predicted to lie on the
face of the helix that points away from the DNA-contacting
b-sheet (Fig. 5). Outside of the a-helix, similar mutations are
not present in ANT-AP2R1 and ANT-AP2R2. For example,
mutations in at least three amino acids (V317, Y318 and L319)
of ANT-AP2R1 that align with the third b-strand (b3) of
AtERF1 result in decreased ANT activity, yet no mutations in
the corresponding positions of ANT-AP2R2 were isolated in
the screen. Similarly, three residues (S384, Y386 and R387)
Figure 1. Transcriptional activation by ANT when bound to the consensus binding site in yeast. Schematics of full-length (ANT1±555), internally deleted
(ANTD281±357, ANTD383±451), truncated (ANT1±451) or mutated (ANTA423T) ANT proteins are shown on the left. ANTD281±357 lacks the ®rst AP2 domain
(AP2-R1), ANTD383±451 lacks the second AP2 domain (AP2-R2), ANT1±451 lacks the C-terminal 104 amino acids and ANTA423T contains a replacement of
A423 by T. Each of these effector plasmids was tested for their ability to activate expression of the reporter plasmid. The reporter plasmid contained lacZ
under the control of three ANT-binding sites and the TATA region of the CYC1 promoter. Relative transcriptional activation conferred by the different ANT
proteins are indicated on the right. All values are expressed relative to full-length ANT (1.00). Error bars show standard deviations.
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located near the N-terminus of ANT-AP2R2 were identi®ed in
the screen but no similar positions in ANT-AP2R1 were
isolated.
Few mutations map to predicted DNA-contacting
residues
Few of the identi®ed mutations map to the DNA-contacting
positions of AtERF1 that are within and adjacent to the b-
strands. One single mutant (Y318C) corresponds to the base
and backbone-contacting W172 residue of AtERF1. Three
double mutants (T288A L319P, W301R E421G and L227P
R387G) potentially have mutations corresponding to AtERF1
DNA-contacting residues. T288, W301 and R387 correspond
to R150, R162 and R147, respectively. The single mutants
T288A, W301R and R387G were constructed to determine
the effects of these individual mutations on b-galactosidase
activity. T288A mutants exhibited high b-galactosidase activ-
ity, W301R mutants produced low b-galactosidase activity and
R387G mutants showed signi®cantly reduced b-galactosidase
activity (Table 1). Thus, three residues in ANT (W301, Y318
and R387) aligning to DNA-contacting positions within
AtERF1 alter the ability of ANT to activate a reporter gene.
Table 1. Mutants isolated in the yeast genetic screen or constructed by PCR
Clone Mutation(s) Phenotype Predicted location Relative b-gal activity DNA binding
ANT Blue 1.00 +++
R285G Blue R1 0.18 6 0.10
E5-15 V287D White R1-b1 0.00062 6 0.00015
E5-52 V287A, N303D White R1-b1, R1
E5-41 T288A, L319P White R1-b1, R1-b3
T288A Blue R1-b1 0.62 6 0.037
H290A Light blue R1-b1 0.017 6 0.0042
E4-11 W301R, E421G Light blue R1-b2, R2-a
W301R Light blue R1-b2 0.016 6 0.0057 ++
E5-52 N303D, V287A White R1, R1-b1
E5-5 G314R, Y353C White R1, R1
E1-2 V317D Light blue R1-b3 0.0065 6 0.00055 +++
E5-33 Y318C White R1-b3 0.00069 6 0.00031 +
E5-43 Y318C White R1-b3 0.00069 6 0.00031 +
E3-5 L319Q White R1-b3 0.00034 6 0.000068 +
E5-2 L319P White R1-b3
E5-26 L319P White R1-b3
E8-9 L319P White R1-b3
E8-5 L319P, E356G White R1-b3, R1
E5-41 L319P, T288A White R1-b3, R1-b1
E6-1 Y322F, Y386D White R1-b3, R2
E1-1 D333E, I452T White R1-a, C-term
E1-4 D333G White R1-a 0.00067 6 0.00014 ++
E5-4 L337P White R1-a 0.00043 6 0.000067 +
E4-6 L337P, R387G White R1-a, R2
E5-5 Y353C, G314R White R1, R1
E8-5 E356G, L319P White R1, R1-b3
E5-44 E358G White L
E5-50 H371P, V389A White L, R2-b1
E2-9 F379S White L 0.00092 6 0.00021
E5-18 F379S White L 0.00092 6 0.00021
E5-37 F379S White L 0.00092 6 0.00021
E4-13 S380P Light blue L 0.0092 6 0.0025 ++
G382D White L 0.00095 6 0.000064
E5-27 S384P White R2
E5-34 S384P White R2
E6-1 Y386D, Y322F White R2, R1-b3
E4-6 R387G, L337P White R2, R1-a
R387G White R2 0.00053 6 0.000042 ±
E5-50 V389A, H371P White R2-b1, L
V389D Blue R2-b1 0.41 6 0.038
H392A Blue R2-b1 0.22 6 0.065
H393A Blue R2 0.50 6 0.13
Y412C Blue R2-b3 0.20 6 0.037
L413Q Light blue R2-b3 0.041 6 0.015
E4-11 E421G, W301R Light blue R2-a, R1-b2
A423T White R2-a 0.00091 6 0.00033 +
E5-42 D427G White R2-a 0.00041 6 0.00010 +
E6-39 I431S Light blue R2-a 0.0031 6 0.0010 ++
E1-1 I452T, D333E White C-term, R1-a
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Mutations in two of these positions, Y318 in ANT-AP2R1 and
R387 in ANT-AP2R2, cause dramatic reductions in function
as measured in the yeast assay.
Analyses of site-directed mutants
Even though there is high sequence similarity between the ®rst
and second AP2 repeats of ANT, few corresponding mutations
in each repeat were identi®ed in the screen. It is possible that
such mutations would have been isolated with additional
screening. To address further whether the two AP2 repeats of
ANT might interact differently with DNA, additional amino
acid substitutions were made in ANT and assayed in the BK1
system. For several mutants (V287D, Y318C, L319Q and
R387G) that exhibited no b-galactosidase activity in the
screen, I made the corresponding amino acid substitution in
the other AP2 repeat (V389D, Y412C, L413Q and R285G,
respectively). V389D, Y412C and R285G mutants exhibited
high levels of b-galactosidase activity ranging between 18 and
40% that of wild-type ANT and produced a blue color in the
colony-lift assay (Table 1). The L413Q mutant displayed a
partial loss of function in the yeast assay giving a light blue
color in the colony-lift ®lter assay and b-galactosidase activity
that was ~4% that of wild-type ANT (Table 1).
The importance of one additional DNA-contacting position
(R152) in AtERF1 was investigated in each of the AP2 repeats
of ANT. Histidines are found at the corresponding locations in
ANT-AP2R1 and ANT-AP2R2 (H290 and H392, respect-
ively). In ANT-AP2R2, a second histidine (H393) is found
next to H392. All three positions were mutated to alanine and
assayed in BK1. The H290A mutation produced a light blue
color in the colony-lift assay and exhibited signi®cantly lower
b-galactosidase activity compared to ANT (Table 1). The
H392A and H393A mutations confer high levels of
b-galactosidase activity (Table 1). Thus, in only one
(L319Q/L413Q) of the ®ve pairs tested did identical amino
acid changes in the two AP2 repeats of ANT produce similar
b-galactosidase phenotypes in yeast.
One additional mutant was assayed in the BK1 system. The
G382D mutation, corresponding to the molecular defect
present in the strong ant-2 mutation, contains a replacement
of a highly conserved glycine at the last position of the linker
(2). Yeast expressing the G382D mutant gave a white
phenotype in the colony-lift ®lter assay (Table 1).
Characterization of the in vitro DNA binding ability of
several mutants
The ability of several of these mutants to bind DNA in vitro
was examined using gel mobility shift assays. Mutations in
ANT-AP2R1 (W301R, V317D, Y318C, L319Q, D333G and
L337P), ANT-AP2R2 (R387G, D427G and I431S) and the
linker (S380P) were chosen for these studies. This group of
mutants corresponds to both partial (W301R, V317D, S380P
and I431S) and complete (Y318C, L319Q, D333G, L337P,
R387G and D427G) loss of yeast activity mutants. In addition,
some members of the group correspond to positions that may
contact DNA (W301R, V317D, Y318C, L319Q, S380P and
Figure 2. Method used to generate mutations in the DNA-binding domain
of ANT. BsiWI and SacI restriction sites engineered into the ANT sequence
allowed the production of a gapped ANT plasmid lacking the DNA-binding
domain. In vivo recombination occurred between PCR products generated
with Taq polymerase and the gapped plasmid. Yeast transformants contain-
ing the repaired ANT plasmid were screened for b-galactosidase activity
using a colony-lift ®lter assay. Clones producing reduced (light blue) or no
(white) b-galactosidase activity were then analyzed using western blots and
an antibody against the DHA epitope present at the C-terminus of ANT.
Figure 3. Western blots and colony-lift ®lter assays of some mutants
identi®ed in the yeast screen. (A) Western blot of individual yeast clones.
ANT (indicated with the arrow) is detected using the anti-HA antibody. No
protein is detected in protein extracts from yeast expressing an ANT protein
lacking the DHA tag (ANT) or the mutant E3-8. Full-length ANT protein is
detected in extracts from ANT-DHA and the mutants E1-1, E1-2, E1-4,
E2-9 and E3-5. A smaller ANT fragment (marked with an asterisk) is also
detected in some of the mutants. (B) Colony-lift ®lter b-galactosidase assays
for yeast expressing ANT (blue phenotype), V317D (light blue phenotype)
and D333G (white phenotype).
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R387G), while others correspond to positions that appear
unlikely to contact DNA (D333G, L337P, D427G and I431S).
The mutations were created and assayed in the context of the
two AP2 repeats of ANT, as this was the ANT construct
previously used in DNA binding characterization (called
ANT-AP2R1R2) (14). All tested proteins from mutants that
gave a light blue b-galactosidase phenotype were able to bind
the ANT consensus site in vitro with fairly high af®nity. The
V317D mutant had a DNA binding ability comparable to that
of ANT while W301R, S380P and I431S bound with
decreased ability (Fig. 6 and Table 1). Five of the six proteins
from mutants that gave a white colony-lift b-galactosidase
phenotype showed signi®cantly decreased DNA binding
(Y318C, L319Q, L337P and D427G) or absolutely no DNA
binding (R387G). The lone exception was D333G; this protein
exhibited relatively high DNA binding ability but had no
Figure 4. Mapping of mutants onto the ANT sequence. Each of the two AP2 repeats of ANT is shown aligned with the single ERF domain of AtERF1.
Secondary structural elements as determined in the AtERF1 structure (13) are indicated above the AtERF1 sequence. The ®rst and last amino acids are
numbered at the left and right of each sequence. Hydrophobic residues stabilizing the packing of these secondary structural elements are shaded with gray.
DNA-contacting amino acids of AtERF1 are shown in bold (base-contacting) and/or underlined (phosphate backbone-contacting). (A) Summary of mutants
identi®ed in the yeast genetic screen. Amino acids shown in red correspond to mutations conferring a white phenotype in the colony-lift ®lter assay while
amino acids shown in blue correspond to mutations conferring a light blue phenotype in the colony-lift ®lter assay. Residues shown in green were present in a
double mutant and thus their individual effects in the yeast system could not be determined. (B) Summary of all mutants with con®rmed white (shown in
red), light blue (shown in blue) or blue (shown in green) phenotypes in the colony-lift ®lter assay.
Figure 5. Structure of AtERF1 and homology models of ANT-AP2R1 and ANT-AP2R2. a-Helices are indicated in red and b-strands in yellow. D187 and
F191 of AtERF1 lie on the face of the helix pointing away from the b-sheet. The corresponding positions in ANT-AP2R1 (D333 and L337) and ANT-AP2R2
(D427 and I431) lie on this same face of the predicted helices.
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activity in the yeast b-galactosidase assay. Thus, the in vitro
DNA binding results are generally in good agreement with the
yeast in vivo results.
DISCUSSION
Different positions within each AP2 domain of ANT
appear to play important roles in DNA recognition
Using a genetic screen in yeast, I identi®ed a number of amino
acids that disrupt the ability of ANT to activate expression of a
reporter gene under the control of ANT-binding sites. Most of
these mutations do not map to positions corresponding to
AtERF DNA-contacting positions and thus their importance
could not have been predicted from the AtERF structure. To
test whether these mutations did indeed affect DNA binding,
several were subsequently assayed using gel mobility shift
assays. For almost all the mutants tested, the decreased
activity in vivo correlated well with the decreased DNA
binding activity measured in vitro, con®rming the validity of
the approach. The different activities of the D333G mutant in
the two assays may result from the different protein contexts
utilized in the yeast and gel mobility shift experiments. This
mutation displayed a more severe phenotype when assayed in
the context of the full-length protein, perhaps due to an effect
on a region of the protein not present in the shortened version
used in the in vitro DNA binding experiments. Most mutants
still possessed some DNA binding ability, suggesting that the
majority of the mutations did not signi®cantly affect the
overall folding of the protein but had more speci®c alterations
that affected DNA binding af®nity.
This genetic screen and subsequent targeted mutagenesis
have identi®ed 19 residues that are likely to play important
roles in DNA binding and at least six residues that are
dispensable for DNA binding (summarized in Fig. 4B).
Several residues were isolated at least twice, suggesting
that the screen was approaching saturation. Based on the
number and severity of the mutations, the amino acids most
critical to DNA binding by ANT correspond to those within
ANT-AP2R1 that align with b3 of AtERF1, those at the
C-terminal part of the linker and those at the N-terminus of
ANT-AP2R2. These results suggest that the two AP2 repeats
of ANT differ in their interactions with this DNA-binding site.
The two AP2 repeats might use different positions to contact
the DNA. Alternatively, similar positions might be used but
contribute differently to the overall af®nity for DNA. The
former appears more likely as the ANT consensus site does not
consist of two similar half-sites, even though ANT-AP2R1
and ANT-AP2R2 contain identical amino acids at most of the
positions identi®ed in this study.
No in vivo targets of ANT regulation have been identi®ed.
Thus, the level of similarity between the in vitro determined
ANT consensus binding site (used in this study) and natural
promoter elements bound by ANT in vivo is not known. Once
such sites have been identi®ed, it will be important to
determine whether the residues identi®ed in this study mediate
critical DNA interactions in the context of these other sites.
Such studies will be necessary to determine if the same amino
acids are used to contact native ANT target promoters and to
determine whether differential DNA interactions by each AP2
repeat is a natural feature of the molecular recognition of DNA
by ANT.
Importance of the linker in ANT±DNA interactions
The linker connecting the two AP2 repeats of ANT appears to
be an important component for DNA recognition as demon-
strated by the conservation of the linker in members of the
AP2 subfamily (reviewed in 9) and the fact that mutations in
several positions within the linker negatively affect DNA
binding. Several families of transcription factors use tandem
repeats of structurally independent DNA-binding domains to
contact DNA. The linkers connecting these domains appear to
play several different roles in these proteins. In zinc ®nger
proteins and Myb proteins, the DNA-binding domains (zinc
®ngers or helix±turn±helix related motifs) are connected by
well conserved linkers (5 or 13 amino acids) that allow the
independent structural units to follow the turn of the DNA
helix and make continuous contacts in the major groove. The
importance of these linkers thus appears to derive primarily
from a role in positioning of the DNA-binding domains
(22,23).
Two other families of proteins that contain two DNA-
binding domains are the paired and POU domain proteins. In
the paired domain, a conserved linker of 16 amino acids makes
extended contacts along the minor groove while connecting
two helix±turn±helix type domains that contact the major
groove (24). These linkers thus directly contribute to DNA
binding af®nity and speci®city. In POU domain proteins, the
linker sequence is not well conserved, of variable length
(15±56 amino acids) and seems to primarily serve a tethering
role linking the two helix±turn±helix motifs of the POU-
speci®c (POUS) and POU-homeodomain (POUH) domains.
This ¯exible linker allows POU domain proteins to recognize
diverse DNA sequences due to alterations in the positioning,
spacing and orientation of the POUS and POUH domains
(reviewed in 25). The conserved nature of the linker in AP2-
like proteins and the identi®cation of several linker residues in
ANT that are indispensable for DNA binding suggests that this
region directly contacts DNA or functions in positioning the
two AP2 repeats on DNA.
Figure 6. Gel mobility shift assay of ANT-AP2R1R2 and mutants. The
experiment used radiolabeled ANT consensus binding site 15 (14). Equal
amounts of protein (~100 ng), as estimated from the intensity of Coomassie
Brilliant Blue stained gels, were loaded in each lane. B and F denote the
positions of bound and free probe, respectively. The fractional saturation of
bound probe to total probe is shown below the gel. Weak DNA binding was
observed for D427G at higher protein concentration.
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Possible effects of mutations in the predicted a-helical
regions of ANT
Since the a-helix does not make any DNA contacts in
AtERF1, few residues in this region would be expected to
affect DNA binding. Only six of the 24 mutations from the
screen were located in this region. However, ®ve of the six
mutations map to the same two positions (D333/D427 and
L337/I431) within the predicted a-helix of both AP2 repeats.
Of particular surprise is that these two positions are predicted
to lie on the exposed face of the helix (Fig. 5). Thus, their
effect on DNA binding does not appear to derive from simply
decreased stabilization of the packing between the predicted
a-helix and the rest of the AP2 domain as might be predicted
for the A423T mutation.
These residues could be involved in contacting other
regions of ANT, although the D333G, L337P, D427G and
I431S mutants all showed reduced DNA binding activity
in vitro when they are assayed in the context of an ANT
protein consisting of just the two AP2 repeats and the linker.
These amino acids seem unlikely to be involved in interactions
with components of the general transcriptional machinery as
the transcriptional activation domain of ANT is located in the
N-terminal half (C.Sulli and B.A.Krizek, unpublished obser-
vations). A third possibility is that the mutations more
indirectly affect DNA binding by altering the structure of
the AP2 domain. Proline and glycine tend not to be found in
a-helices as they are helix-destabilizing residues. Thus, it is
possible that these mutations prematurely terminate the helix
and decrease the stability of the protein±DNA complex. Such
an idea could be tested by mutating the amino acids in these
positions to residues compatible with an a-helical structure
and testing them in the yeast BK1 assay.
Members of the AP2 and ERF subfamilies may use
distinct modes for DNA binding
One surprising result from the screen was that few residues in
ANT predicted to be DNA-contacting residues based on an
alignment with AtERF1 were identi®ed as conferring a loss of
function phenotype in yeast. Of the three positions identi®ed
(W301R, Y318C and R387G), R387G showed the most
dramatic losses of activity in vivo and in vitro. Site-directed
mutations of additional positions in ANT (R285, T288, H290,
H392 and Y412) that correspond to DNA-contacting positions
in AtERF1 con®rmed that most of these alterations do not
disrupt ANT function in the yeast assay. Of these mutants,
only H290A showed any loss of activity in the yeast assay.
This suggests that the mode of DNA binding by ANT is
distinct from that of AtERF1. However, it is also possible that
these amino acids have critical roles in DNA binding when
ANT is bound to a natural binding site. Such investigations
await the identi®cation of in vivo target sites of ANT.
Any differences in DNA binding between ANT and
AtERF1 could arise from a different three-dimensional
structure of the AP2 domains of ANT and consequently
different interactions with DNA. Alternatively, each of the
AP2 domains could fold into a structure that resembles the
ERF domain but which has a distinct mode of DNA
recognition due to the covalent linkage of two domains.
Structural studies are needed to better address the
three-dimensional structure of the AP2 domain and the role
of the linker in this class of transcription factors.
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